Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
ABSTRACT Background Triple‐negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Previous studies have found that fibroblast growth factor receptor 4 (FGFR4) plays a crucial role in tumor development and metastasis. However, the potential role and underlying mechanisms of FG...
Saved in:
| Main Authors: | Jinhui Ye, Song Wu, Qiang Quan, Feng Ye, Jinhui Zhang, Cailu Song, Yidan Fan, Huijiao Cao, Hailin Tang, Jianfu Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70439 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related Arrhythmogenic Activities in the Heart
by: Roshan Paudel, et al.
Published: (2024-11-01) -
Dual calcium-voltage optical mapping of regional voltage and calcium signals in intact murine RyR2-R2474S hearts
by: Yangpeng Li, et al.
Published: (2024-12-01) -
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01) -
Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4
by: Qing Luo, et al.
Published: (2025-07-01) -
NAD+ dyshomeostasis in RYR1-related myopathies
by: Tokunbor A. Lawal, et al.
Published: (2025-08-01)